复方血栓通联合羟苯磺酸钙治疗糖尿病并发症玻璃体积血的疗效观察  

The curative effect observation on fufangxueshuantong combined calcium dobesilate for diatetes complications vitreous hemorrhage

作　　者：李树权[1] 

机构地区：[1]天津市第五中心医院,天津300450

出　　处：《临床医药实践》2014年第5期346-348,共3页Proceeding of Clinical Medicine

摘　　要：目的:观察复方血栓通联合羟苯磺酸钙治疗玻璃体积血的临床疗效。方法:将68例玻璃体积血患者随机分为两组,治疗组35例,在常规治疗基础上口服复方血栓通和羟本磺酸钙;对照组33例,给予芦丁、肌苷片、云南白药、维生素类药等常规治疗。比较两组患者的疗效及并发症。结果:治疗组30 d内治愈率等方面明显优于对照组。结论:复方血栓通联合羟苯磺酸钙治疗玻璃体积血的疗效较好。Objective：To observe the clinical curative effect of fufangxueshuantong combined calcium dobesilate for dia- tetcs complications vitreous hemorrhage. Methods ： Sixty - eight patients with vitreous hemorrhage were randomly divided into two groups, the treatment group 35 examples on the basis of conventional treatment of oral fufangxueshuantong and calcium do- besilate. Control group 33 cases to luding,jiganpian ,yunnanbaiyao ,vitamin drugs such as conventional treatment. Compare the curative effect of two groups of patients. Results ：The cure rate within 30 days of treatment group was obviously better than the control group. Conclusion ：The curative effect of fufangxueshuantong combined calcium dobesilate is better for the treatment of vitreous hemorrhage.

关 键 词：复方血栓通 羟本磺酸钙 玻璃体积血 

分 类 号：R587.1[医药卫生—内分泌]